Longer-term tofacitinib effectiveness for the treatment of ulcerative colitis: Two-year outcomes from a UK observational cohort study

被引：0
|
作者：
Honap, S. [1 ,2 ]
Sharma, E. [1 ]
Ray, S. [1 ]
Mawdsley, J. [1 ]
Anderson, S. [1 ]
Samaan, M. [1 ]
Pavlidis, P. [1 ,2 ]
Irving, P. [1 ,2 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, IBD Ctr, Dept Gastroenterol, London, England
[2] Kings Coll London, Sch Immunol & Microbial Sci, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P430
引用
收藏
页码：I414 / I415
页数：2
相关论文
共 50 条
  • [41] Tofacitinib in Treatment-Refractory Moderate to Severe Ulcerative Colitis: Real-World Experience from a Retrospective Multicenter Observational Study
    Hoffmann, Peter
    Globig, Anna-Maria
    Thomann, Anne K.
    Grigorian, Maximilian
    Krisam, Johannes
    Hasselblatt, Peter
    Reindl, Wolfgang
    Gauss, Annika
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 13
  • [42] A Two-year Retrospective Observational Cohort Study of Benzodiazepine Overdose Cases in the Emergency Department
    Giftson, John
    Hazra, Darpanarayan
    Chandy, Gina M.
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2025, 29 (03) : 230 - 235
  • [43] Two-year outcomes of Elektra prosthesis for trapeziometacarpal osteoarthritis: a longitudinal cohort study
    Hernandez-Cortes, P.
    Pajares-Lopez, M.
    Robles-Molina, M. J.
    Gomez-Sanchez, R.
    Toledo-Romero, M. A.
    De Torres-Urrea, J.
    JOURNAL OF HAND SURGERY-EUROPEAN VOLUME, 2012, 37E (02) : 130 - 137
  • [44] Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study
    Danese, Silvio
    Hart, Ailsa
    Dignass, Axel
    Louis, Edouard
    D'Haens, Geert
    Dotan, Iris
    Rogler, Gerhard
    D'Agay, Laurence
    Iannacone, Claudio
    Peyrin-Biroulet, Laurent
    BMJ OPEN GASTROENTEROLOGY, 2016, 3 (01):
  • [45] Predictors of outcomes in exercisers with Parkinson disease: A two-year longitudinal cohort study
    Combs-Miller, Stephanie A.
    Moore, Elizabeth S.
    NEUROREHABILITATION, 2019, 44 (03) : 425 - 432
  • [46] Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study
    Straatmijer, T.
    Biemans, V. B. C.
    Hoentjen, F.
    de Boer, N. K. H.
    Bodelier, A. G.
    Dijkstra, G.
    van Dop, W.
    Haans, J. J. L.
    Jansen, J. M.
    Maljaars, P. W. J.
    van der Marel, S.
    Oldenburg, B.
    Ponsioen, C. Y.
    Visschedijk, M. C.
    de Vries, A. C.
    West, R.
    van der Woudeu, C. J.
    Pierik, M.
    Duijvestein, M.
    van der Meulen-de Jong, A. E.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S319 - S319
  • [47] Clinical and endoscopic outcomes of one year golimumab treatment in patients with active ulcerative colitis: A real-life observational study
    Berends, S.
    Strik, A.
    Jansen, J.
    de Boer, N.
    Brandse, J.
    D'Haens, G.
    Mathot, R.
    Loewenberg, M.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S459 - S460
  • [48] Long-term outcomes of adalimumab treatment in Korean patients with ulcerative colitis: A hospital-based cohort study
    Oh, Eun Hye
    Song, Eun Mi
    Lee, Sun-Ho
    Chang, Kiju
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Ye, Byong Duk
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 148 - 148
  • [49] Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study
    Macaluso, Fabio Salvatore
    D'Antonio, Elvira
    Fries, Walter
    Viola, Anna
    Ksissa, Omar
    Cappello, Maria
    Muscarella, Stefano
    Belluardo, Nunzio
    Giangreco, Emiliano
    Mocciaro, Filippo
    Di Mitri, Roberto
    Ferracane, Concetta
    Vitello, Alessandro
    Grova, Mauro
    Renna, Sara
    Casa, Angelo
    De Vivo, Simona
    Ventimiglia, Marco
    Orlando, Ambrogio
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 15 - 20
  • [50] Safety and effectiveness of adalimumab in the treatment of ulcerative colitis: results from a large-scale, prospective, multicenter, observational study
    Ogata, Haruhiko
    Hagiwara, Takashi
    Kawaberi, Takeshi
    Kobayashi, Mariko
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2021, 19 (04) : 419 - 429
12345